Published in Eur J Epidemiol on January 01, 2005
The clinical decision analysis using decision tree. Epidemiol Health (2014) 0.89
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Markov models in medical decision making: a practical guide. Med Decis Making (1994) 8.14
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Hip fracture. N Engl J Med (1996) 5.96
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med (1990) 4.32
The Markov process in medical prognosis. Med Decis Making (1983) 3.58
Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst (1994) 3.45
Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA (1997) 3.18
Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA (2001) 3.13
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Rate of mortality for elderly patients after fracture of the hip in the 1980's. J Bone Joint Surg Am (1987) 2.63
A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med (1982) 2.56
A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med (1982) 2.49
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation (1995) 2.08
The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA (1992) 1.98
Optimal management of suspected lower-extremity deep vein thrombosis. An evaluation with cost assessment of 24 management strategies. Arch Intern Med (1992) 1.94
Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995. CMAJ (2000) 1.72
Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst (1994) 1.69
Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer (2000) 1.61
Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. Arch Intern Med (1998) 1.58
Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992. Am J Epidemiol (1995) 1.53
Competing risks in mortality analysis. Annu Rev Public Health (1991) 1.52
Functional recovery after fracture of the hip. J Bone Joint Surg Am (1994) 1.51
Competing risks analysis using Markov chains: impact of cerebrovascular and ischaemic heart disease in cancer mortality. Int J Epidemiol (2001) 1.48
Failure of estrogen plus progestin therapy for prevention. JAMA (2002) 1.26
The Stroke Prevention Policy Model: linking evidence and clinical decisions. Ann Intern Med (1997) 1.16
Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med (1990) 1.16
Clinical practice. Postmenopausal hormone-replacement therapy. N Engl J Med (2001) 1.15
Life expectancy biases in clinical decision modeling. Med Decis Making (1995) 0.97
Cost-effectiveness of hormone replacement therapy after the menopause. Baillieres Clin Obstet Gynaecol (1991) 0.92
Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. CMAJ (1994) 0.87
The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis. Rheum Dis Clin North Am (2001) 0.85
Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered. Am J Med (1986) 0.85
Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet Gynecol (1994) 0.80
Cost-effectiveness of carotid endarterectomy. Neurosurgery (1996) 0.79
Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Arch Intern Med (1999) 0.78
Estimation of breast cancer risk by women aged 40 and over: a population-based study. Can J Public Health (1998) 0.76
Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med (2012) 2.16
Varying conceptions of competence: an analysis of how health sciences educators define competence. Med Educ (2012) 1.94
Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem (2009) 1.85
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Delirium in older emergency department patients discharged home: effect on survival. J Am Geriatr Soc (2003) 1.61
Developing an efficient model to select emergency department patient satisfaction improvement strategies. Ann Emerg Med (2005) 1.54
The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis. J Clin Psychiatry (2002) 1.49
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf (2015) 1.45
Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res (2006) 1.41
Mutations in NOTCH2 in families with Hajdu-Cheney syndrome. Hum Mutat (2011) 1.25
Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity. Int J Technol Assess Health Care (2008) 1.19
Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology (2008) 1.18
Training family physicians in shared decision making for the use of antibiotics for acute respiratory infections: a pilot clustered randomized controlled trial. Health Expect (2011) 1.17
Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol (2002) 1.15
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf (2014) 1.14
Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab (2005) 1.14
Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother (2005) 1.12
Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS). Schizophr Res (2011) 1.12
Does training family physicians in shared decision making promote optimal use of antibiotics for acute respiratory infections? Study protocol of a pilot clustered randomised controlled trial. BMC Fam Pract (2007) 1.11
High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep (2013) 1.11
Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant (2007) 1.09
Effect of an educational intervention on optimizing antibiotic prescribing in long-term care facilities. J Am Geriatr Soc (2007) 1.09
The costs of colonoscopy in a Canadian hospital using a microcosting approach. Can J Gastroenterol (2008) 1.08
Feasibility of a randomised trial of a continuing medical education program in shared decision-making on the use of antibiotics for acute respiratory infections in primary care: the DECISION+ pilot trial. Implement Sci (2011) 1.07
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol (2005) 1.05
Impact of a continuing education program on community pharmacists' interventions and asthma medication use: a pilot study. Ann Pharmacother (2007) 1.02
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. Clin Ther (2002) 1.02
Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med (2009) 1.01
Infectious complications following conversion to buttonhole cannulation of native arteriovenous fistulas: a quality improvement report. Am J Kidney Dis (2011) 1.00
Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer (2005) 1.00
A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification. J Gastrointest Surg (2014) 1.00
Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf (2007) 0.99
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study. Cancer (2008) 0.99
Recognizing osteoporosis and its consequences in Quebec (ROCQ): background, rationale, and methods of an anti-fracture patient health-management programme. Contemp Clin Trials (2007) 0.98
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada. Clin Ther (2007) 0.97
Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res (2011) 0.97
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing (2008) 0.93
Contemporary disease management in Quebec. Healthc Q (2008) 0.92
The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec. Can J Clin Pharmacol (2008) 0.92
Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol (2008) 0.90
Activity-based costing evaluation of a [(18)F]-fludeoxyglucose positron emission tomography study. Health Policy (2009) 0.90
Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer. Clin Lung Cancer (2003) 0.90
Benzodiazepine use and quality of sleep in the community-dwelling elderly population. Aging Ment Health (2010) 0.89
Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial. Pituitary (2014) 0.89
Career trajectories of nurses leaving the hospital sector in Ontario, Canada (1993-2004). J Adv Nurs (2009) 0.89
Health survey data on potentially inappropriate geriatric drug use. Ann Pharmacother (2002) 0.87
Does clinical trial subject selection restrict the ability to generalize use and cost of health services to "real life" subjects? Int J Technol Assess Health Care (2003) 0.85
Suboptimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics. J Am Geriatr Soc (2002) 0.85
1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6). Am J Physiol Endocrinol Metab (2004) 0.85
Depression and mortality in the visually-impaired, community-dwelling, elderly population of Quebec. Acta Ophthalmol (2007) 0.85
Factors associated with persistence of cholinesterase inhibitor treatments in the elderly. Pharmacoepidemiol Drug Saf (2010) 0.84
Pamidronate prevents the development of skeletal metastasis in nude mice transplanted with human breast cancer cells by reducing tumor burden within bone. Int J Oncol (2003) 0.84
Patterns of antidepressant use in Quebec children and adolescents: trends and predictors. Psychiatry Res (2010) 0.83
Methodological gaps in the assessment of risk minimization interventions: a systematic review. Pharmacoepidemiol Drug Saf (2014) 0.83
Atypical femoral fractures and bone turnover. N Engl J Med (2011) 0.82
Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women. J Clin Endocrinol Metab (2007) 0.82
Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf (2008) 0.82
Impact of prescriber nonresponse on patient representativeness. Epidemiology (2008) 0.82
Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population. J Affect Disord (2008) 0.82
Role of zoledronic acid in the prevention and treatment of osteoporosis. Clin Interv Aging (2011) 0.82
Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials. Support Care Cancer (2005) 0.82
Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals. J Hypertens (2015) 0.82
Activity-based costing evaluation of [18F]-fludeoxyglucose production. Eur J Nucl Med Mol Imaging (2007) 0.81
A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care. Can J Gastroenterol (2010) 0.81
Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study. J Clin Densitom (2008) 0.81
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers. Br J Clin Pharmacol (2009) 0.81
The association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatry (2010) 0.80
Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma. Acta Oncol (2010) 0.80
Men had a higher risk of recurrent venous thromboembolism than women: a large population study. Gend Med (2012) 0.80
Cost-effectiveness of alternative approaches in the management of dyspepsia. Int J Technol Assess Health Care (2003) 0.80
Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf (2005) 0.79
Cost comparison of open approach, transoral laser microsurgery and transoral robotic surgery for partial and total laryngectomies. Eur Arch Otorhinolaryngol (2014) 0.79
NSAID use profiles derived from reimbursement data in France. Therapie (2005) 0.79
Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approach. Value Health (2011) 0.78
Microwave irradiation of ethanol-fixed bone improves preservation, reduces processing time, and allows both light and electron microscopy on the same sample. J Histochem Cytochem (2004) 0.78
Effectiveness of antibiotics for acute sinusitis in real-life medical practice. Br J Clin Pharmacol (2010) 0.78
Simulation and comparison of progression-free survival among patients with non-squamous non-small-cell lung cancer receiving sequential therapy. Expert Rev Anticancer Ther (2014) 0.78
Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. Br J Clin Pharmacol (2010) 0.77
Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results from the ESA study. Can J Aging (2012) 0.77
Case series in drug safety: a review to determine characteristics and quality. Drug Saf (2010) 0.77
Economic analysis of HPV-vaccines: not so simple? Vaccine (2007) 0.77
Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium. Pharm World Sci (2002) 0.77
Avoidable admissions and repeat admissions: what do they tell us? Healthc Q (2007) 0.76
Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis. Int J Technol Assess Health Care (2002) 0.76
Benzodiazepine utilization patterns in Alzheimer's disease patients. Pharmacoepidemiol Drug Saf (2003) 0.76
Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia. Gastrointest Endosc (2003) 0.76
Cost-efficacy analysis of ondansetron regimens for control of emesis induced by noncisplatin, moderately emetogenic chemotherapy. Am J Health Syst Pharm (2002) 0.76
Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia? Ther Apher Dial (2010) 0.76
Effect of feedback letters to physicians and pharmacists on the appropriate use of medication in the treatment of asthma. J Asthma (2008) 0.76
Impact of a protocol for prevention of ventilator-associated pneumonia. Ann Pharmacother (2007) 0.76
The Value of Performance Measurement in Promoting Improvements in Women's Health. Healthc Policy (2009) 0.75